Who owns Immunovant, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IMVT from SEC Form 13F filings across 233 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 233 institutions disclosed 109.0M shares of Immunovant, Inc. worth $3.68B — about 52.7% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
233
13F holders
$3.68B
value, 2026 filers
52.7%
of shares outstanding (109.0M sh)
37
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of IMVT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 15.7M | $530.5M | 0.0% | 7.6% | -3.0% |
| 2 | Deep Track Capital, LP | 9.2M | $309.5M | 5.0% | 4.4% | -1.9% |
| 3 | BlackRock, Inc. | 7.4M | $250.8M | 0.0% | 3.6% | +3.4% |
| 4 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 6.5M | $218.6M | 0.9% | 3.1% | +11.5% |
| 5 | MORGAN STANLEY | 5.7M | $192.0M | 0.0% | 2.8% | +25.4% |
| 6 | Two Seas Capital LP | 4.6M | $155.8M | 1.8% | 2.2% | +46.5% |
| 7 | TCG Crossover Management, LLC | 4.5M | $150.6M | 4.3% | 2.2% | 0.0% |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.3M | $144.1M | 0.0% | 2.1% | +9.1% |
| 9 | STATE STREET CORP | 4.2M | $141.8M | 0.0% | 2% | -9.1% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 4.1M | $138.1M | 0.0% | 2% | +12.3% |
| 11 | RTW INVESTMENTS, LP | 3.2M | $107.3M | 1.1% | 1.5% | 0.0% |
| 12 | JENNISON ASSOCIATES LLC | 2.9M | $98.5M | 0.1% | 1.4% | -11.9% |
| 13 | BAKER BROS. ADVISORS LP | 2.8M | $93.6M | 0.4% | 1.3% | -49.0% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 2.2M | $76.0M | 0.0% | 1.1% | +0.7% |
| 15 | ADAR1 Capital Management, LLC | 2.1M | $71.5M | 3.3% | 1% | -9.2% |
| 16 | Woodline Partners LP | 2.0M | $66.7M | 0.2% | 1% | 0.0% |
| 17 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.8M | $61.0M | 0.0% | 0.9% | -1.3% |
| 18 | ARMISTICE CAPITAL, LLC | 1.7M | $58.7M | 0.7% | 0.8% | +0.1% |
| 19 | GOLDMAN SACHS GROUP INC | 1.6M | $54.1M | 0.0% | 0.8% | -8.5% |
| 20 | T. Rowe Price Investment Management, Inc. | 1.5M | $49.8M | 0.0% | 0.7% | -33.7% |
| 21 | Alpine Global Management, LLC | 1.4M | $46.3M | 8.7% | 0.7% | -0.4% |
| 22 | BANK OF AMERICA CORP /DE/ | 1.4M | $45.7M | 0.0% | 0.7% | +14.4% |
| 23 | D. E. Shaw & Co., Inc. | 1.1M | $37.4M | 0.0% | 0.5% | -10.7% |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.0M | $34.6M | 0.0% | 0.5% | +50.3% |
| 25 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 999,555 | $33.8M | 0.0% | 0.5% | -2.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.